The FLT3N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib.

Details

Language :

English

ISSN :

03618609

Volume :

98

Issue :

12

Database :

Complementary Index

Journal :

American Journal of Hematology

Publication Type :

Academic Journal

Accession number :

173625693

Full Text :

https://doi.org/10.1002/ajh.27096